Fresenius Medical Care Files 6-K Report
Ticker: FMCQF · Form: 6-K · Filed: Sep 19, 2025 · CIK: 1333141
| Field | Detail |
|---|---|
| Company | Fresenius Medical Care Ag (FMCQF) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, press-release
TL;DR
FMS just dropped a 6-K with a press release from yesterday - check it for news.
AI Summary
Fresenius Medical Care AG filed a Form 6-K on September 19, 2025, to report a press release issued on September 18, 2025. The filing does not contain specific financial figures or operational details beyond the announcement of the press release.
Why It Matters
This filing indicates Fresenius Medical Care is providing updated information to the SEC, which could contain material developments for investors.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain new financial data or significant operational changes.
Key Players & Entities
- Fresenius Medical Care AG (company) — Registrant
- September 18, 2025 (date) — Date of Press Release
- September 19, 2025 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to furnish a press release issued by Fresenius Medical Care AG on September 18, 2025, to the Securities and Exchange Commission.
What is the filing date of this report?
This report was filed on September 19, 2025.
What exhibit is included with this Form 6-K?
Exhibit 99.1, a Press Release issued on September 18, 2025, is included with this report.
What is the company's principal executive office address?
The company's principal executive offices are located at Else-Kröner Strasse 1, 61346 Bad Homburg, Germany.
Does Fresenius Medical Care AG file annual reports under Form 20-F or 40-F?
Fresenius Medical Care AG indicates it files annual reports under cover of Form 20-F.
Filing Stats: 176 words · 1 min read · ~1 pages · Grade level 14.5 · Accepted 2025-09-19 07:31:33
Filing Documents
- tm2526545d1_6k.htm (6-K) — 10KB
- tm2526545d1_ex99-1.htm (EX-99.1) — 15KB
- tm2526545d1_ex99-1img1.jpg (GRAPHIC) — 81KB
- 0001104659-25-091447.txt ( ) — 137KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: September 19, 2025 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board